High dose cabergoline in management of ovarian hyperstimulation syndrome  

Oleh:

Ata, Baris ; Seyhan, Ayse ; Orhaner, Serbulent ; Urman, Bulent

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 92 no. 03 (Sep. 2009), page 1168.
Topik: Ovarian hyperstimulation syndrome; vascular endothelial growth factor; cabergoline; dopamine; prevention; treatment

Ketersediaan

Perpustakaan FK Nomor Panggil: F02.K.2009.03 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Objective To describe a case of moderate ovarian hyperstimulation syndrome (OHSS) that was treated with high dose cabergoline. Design Case report. Setting Private assisted reproduction center. Patient(s) A 29-year-old woman who developed early moderate OHSS despite preventive cabergoline administration (0.5 mg/day) following controlled ovarian hyperstimulation for IVF treatment. Intervention(s) Cabergoline dose was increased to 1 mg/day upon diagnosis of OHSS on the second day after oocyte collection and embryo transfer was postponed to the fifth day after oocyte collection. Main Outcome Measure(s) Resolution of OHSS and achievement of healthy live birth. Result(s) OHSS resolved rapidly despite occurrence of pregnancy and patient delivered a healthy boy at term. Conclusion(s) The higher cabergoline dose might have prevented an increase in the severity of OHSS and its prolongation following occurrence of pregnancy. Randomized controlled trials assessing the efficacy and safety of different doses and durations of cabergoline administration in both prophylactic and therapeutic settings are required.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali